Literature DB >> 28534533

Prostate cancer: AR mutations in plasma DNA indicate outcomes.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID: 28534533     DOI: 10.1038/nrclinonc.2017.75

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.

Authors:  V Conteduca; D Wetterskog; M T A Sharabiani; E Grande; M P Fernandez-Perez; A Jayaram; S Salvi; D Castellano; A Romanel; C Lolli; V Casadio; G Gurioli; D Amadori; A Font; S Vazquez-Estevez; A González Del Alba; B Mellado; O Fernandez-Calvo; M J Méndez-Vidal; M A Climent; I Duran; E Gallardo; A Rodriguez; C Santander; M I Sáez; J Puente; D Gasi Tandefelt; A Wingate; D Dearnaley; F Demichelis; U De Giorgi; E Gonzalez-Billalabeitia; G Attard
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.